Log In
|
Recently Purchased
|
Favorites
|
My COAs
|
Cart
(0)
OVERVIEW
INNOVATIONS
COMPANY PROFILE
OUR EXPERTS
FACILITY
OVERVIEW
QUALITY CREDENTIALS
COA EXAMPLES
EXPIRY/RETEST DATES
OVERVIEW
SYNTHESIS
CERTIFIED SOLUTION
STANDARDS
CERTIFICATIONS
PACKAGING
INVENTORY MANAGEMENT
& DISTRIBUTION
OEM & PRIVATE LABEL
REQUEST QUOTE
CATALOG
NEW PRODUCTS
ORDERING INFORMATION
REQUEST/DOWNLOAD
CATALOG
REQUEST CUSTOM QUOTE
SEARCH COAs/SDSs
PAPERS & POSTER
PRESENTATIONS
CONTACT INFORMATION
INTERNATIONAL SALES
CAREERS
LOG IN/REQUEST LOGIN
FAVORITES
RECENTLY PURCHASED
QUICK ORDER
ORDER HISTORY
PURCHASES BY ITEM
MY ACCOUNT'S COAs & SDSs
VIEW CART/CHECK OUT
D-052 / D-052-1ML
updated item number format
N-Desmethyltapentadol
1.0 mg/mL in Methanol |
Certified Reference Material
N-Desmethyltapentadol is a primary urinary and blood metabolite of the analgesic tapentadol (Nucynta®). This certified reference solution is suitable for numerous GC/MS or LC/MS applications from pharmaceutical testing and prescription pain monitoring to forensic analysis or clinical toxicology. Tapentadol is prescribed for treatment of both acute and chronic pain.
Concentration:
1.0 mg/mL
Solvent:
Methanol
Unit Size:
1 mL/ampoule
CAS Number:
1300037-83-5
Chemical Formula:
C
1
3
H
2
1
NO
Molecular Weight:
207.31
Certificate of Analysis:
need a different CoA?
US List Price:
$428.00 EA
Qty:
Components
Related Items
Additional Details
Technical Papers
T-058 / T-058-1ML
Tapentadol HCl, 1.0 mg/mL (as free base)
$257.00
T-059 / T-059-1ML
Tapentadol-D
3
HCl, 100 μg/mL (as free base)
$337.00
T-060 / T-060-1ML
Tapentadol-β-D-glucuronide, 100 μg/mL
$343.00
T-061 / T-061-1ML
Tapentadol-O-sulfate, 100 μg/mL (as free acid)
$306.00
T-119-1ML
Tapentadol-D
3
HCl, 1.0 mg/mL (as free base)
$927.00
Regulatory Control
▶ Canada Test Kit Registration # 61-1124 - no Health Canada import authorization required
read more about ordering regulated substances
Recommended Storage Condition
Freeze
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
View SDS
HS Code
3822.90.0000
▶
Robust LC/MS Application for Bioanalysis of Pain Management Drugs | Craig Aurand, David Bell, Jennifer Claus, and Kara Staurowsky, Supelco, 2012
©
2024
Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products
|
Sitemap
|
Privacy Policy
|
EHS Policy
|
Terms & Conditions
|
Contact